Phosphoproteomic analysis of AML cell lines identifies leukemic oncogenes

Denise K. Walters, Valerie L. Goss, Eric P. Stoffregen, Ting Lei Gu, Kimberly Lee, Julie Nardone, Laura McGreevey, Michael Heinrich, Michael W. Deininger, Roberto Polakiewicz, Brian Druker

Research output: Contribution to journalArticle

49 Citations (Scopus)

Abstract

STAT5 is constitutively phosphorylated in leukemic cells in approximately 70% of acute myeloid leukemia (AML) patients. To identify kinase candidates potentially responsible for STAT5 phosphorylation, we used liquid chromatography-tandem mass spectrometry (LC-MS/MS) mass spectrometry to detect phosphoproteins in AML cell lines. We established TEL-ARG and BCR-ABL fusion proteins as the mechanism underlying STAT5 phosphorylation in HT-93 and KBM-3 cells, respectively. In addition, we identified a JAK2 pseudokinase domain mutation in HEL cells and using siRNA downregulation, established JAK2 as the kinase responsible for phosphorylating STAT5. This study illustrates the benefit of LC-MS/MS mass spectrometry and siRNA for the identification of novel targets and mutations.

Original languageEnglish (US)
Pages (from-to)1097-1104
Number of pages8
JournalLeukemia Research
Volume30
Issue number9
DOIs
StatePublished - Sep 2006

Fingerprint

Myeloid Cells
Oncogenes
Acute Myeloid Leukemia
Cell Line
Small Interfering RNA
Mass Spectrometry
Phosphotransferases
Phosphorylation
Mutation
Phosphoproteins
Tandem Mass Spectrometry
Liquid Chromatography
Down-Regulation
Proteins

Keywords

  • AML
  • Leukemia
  • Phosphopeptide
  • Tyrosine kinases

ASJC Scopus subject areas

  • Cancer Research
  • Hematology
  • Oncology

Cite this

Walters, D. K., Goss, V. L., Stoffregen, E. P., Gu, T. L., Lee, K., Nardone, J., ... Druker, B. (2006). Phosphoproteomic analysis of AML cell lines identifies leukemic oncogenes. Leukemia Research, 30(9), 1097-1104. https://doi.org/10.1016/j.leukres.2006.01.001

Phosphoproteomic analysis of AML cell lines identifies leukemic oncogenes. / Walters, Denise K.; Goss, Valerie L.; Stoffregen, Eric P.; Gu, Ting Lei; Lee, Kimberly; Nardone, Julie; McGreevey, Laura; Heinrich, Michael; Deininger, Michael W.; Polakiewicz, Roberto; Druker, Brian.

In: Leukemia Research, Vol. 30, No. 9, 09.2006, p. 1097-1104.

Research output: Contribution to journalArticle

Walters, DK, Goss, VL, Stoffregen, EP, Gu, TL, Lee, K, Nardone, J, McGreevey, L, Heinrich, M, Deininger, MW, Polakiewicz, R & Druker, B 2006, 'Phosphoproteomic analysis of AML cell lines identifies leukemic oncogenes', Leukemia Research, vol. 30, no. 9, pp. 1097-1104. https://doi.org/10.1016/j.leukres.2006.01.001
Walters DK, Goss VL, Stoffregen EP, Gu TL, Lee K, Nardone J et al. Phosphoproteomic analysis of AML cell lines identifies leukemic oncogenes. Leukemia Research. 2006 Sep;30(9):1097-1104. https://doi.org/10.1016/j.leukres.2006.01.001
Walters, Denise K. ; Goss, Valerie L. ; Stoffregen, Eric P. ; Gu, Ting Lei ; Lee, Kimberly ; Nardone, Julie ; McGreevey, Laura ; Heinrich, Michael ; Deininger, Michael W. ; Polakiewicz, Roberto ; Druker, Brian. / Phosphoproteomic analysis of AML cell lines identifies leukemic oncogenes. In: Leukemia Research. 2006 ; Vol. 30, No. 9. pp. 1097-1104.
@article{7dff62f7c61c429abdef3f1340126104,
title = "Phosphoproteomic analysis of AML cell lines identifies leukemic oncogenes",
abstract = "STAT5 is constitutively phosphorylated in leukemic cells in approximately 70{\%} of acute myeloid leukemia (AML) patients. To identify kinase candidates potentially responsible for STAT5 phosphorylation, we used liquid chromatography-tandem mass spectrometry (LC-MS/MS) mass spectrometry to detect phosphoproteins in AML cell lines. We established TEL-ARG and BCR-ABL fusion proteins as the mechanism underlying STAT5 phosphorylation in HT-93 and KBM-3 cells, respectively. In addition, we identified a JAK2 pseudokinase domain mutation in HEL cells and using siRNA downregulation, established JAK2 as the kinase responsible for phosphorylating STAT5. This study illustrates the benefit of LC-MS/MS mass spectrometry and siRNA for the identification of novel targets and mutations.",
keywords = "AML, Leukemia, Phosphopeptide, Tyrosine kinases",
author = "Walters, {Denise K.} and Goss, {Valerie L.} and Stoffregen, {Eric P.} and Gu, {Ting Lei} and Kimberly Lee and Julie Nardone and Laura McGreevey and Michael Heinrich and Deininger, {Michael W.} and Roberto Polakiewicz and Brian Druker",
year = "2006",
month = "9",
doi = "10.1016/j.leukres.2006.01.001",
language = "English (US)",
volume = "30",
pages = "1097--1104",
journal = "Leukemia Research",
issn = "0145-2126",
publisher = "Elsevier Limited",
number = "9",

}

TY - JOUR

T1 - Phosphoproteomic analysis of AML cell lines identifies leukemic oncogenes

AU - Walters, Denise K.

AU - Goss, Valerie L.

AU - Stoffregen, Eric P.

AU - Gu, Ting Lei

AU - Lee, Kimberly

AU - Nardone, Julie

AU - McGreevey, Laura

AU - Heinrich, Michael

AU - Deininger, Michael W.

AU - Polakiewicz, Roberto

AU - Druker, Brian

PY - 2006/9

Y1 - 2006/9

N2 - STAT5 is constitutively phosphorylated in leukemic cells in approximately 70% of acute myeloid leukemia (AML) patients. To identify kinase candidates potentially responsible for STAT5 phosphorylation, we used liquid chromatography-tandem mass spectrometry (LC-MS/MS) mass spectrometry to detect phosphoproteins in AML cell lines. We established TEL-ARG and BCR-ABL fusion proteins as the mechanism underlying STAT5 phosphorylation in HT-93 and KBM-3 cells, respectively. In addition, we identified a JAK2 pseudokinase domain mutation in HEL cells and using siRNA downregulation, established JAK2 as the kinase responsible for phosphorylating STAT5. This study illustrates the benefit of LC-MS/MS mass spectrometry and siRNA for the identification of novel targets and mutations.

AB - STAT5 is constitutively phosphorylated in leukemic cells in approximately 70% of acute myeloid leukemia (AML) patients. To identify kinase candidates potentially responsible for STAT5 phosphorylation, we used liquid chromatography-tandem mass spectrometry (LC-MS/MS) mass spectrometry to detect phosphoproteins in AML cell lines. We established TEL-ARG and BCR-ABL fusion proteins as the mechanism underlying STAT5 phosphorylation in HT-93 and KBM-3 cells, respectively. In addition, we identified a JAK2 pseudokinase domain mutation in HEL cells and using siRNA downregulation, established JAK2 as the kinase responsible for phosphorylating STAT5. This study illustrates the benefit of LC-MS/MS mass spectrometry and siRNA for the identification of novel targets and mutations.

KW - AML

KW - Leukemia

KW - Phosphopeptide

KW - Tyrosine kinases

UR - http://www.scopus.com/inward/record.url?scp=33745717815&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33745717815&partnerID=8YFLogxK

U2 - 10.1016/j.leukres.2006.01.001

DO - 10.1016/j.leukres.2006.01.001

M3 - Article

VL - 30

SP - 1097

EP - 1104

JO - Leukemia Research

JF - Leukemia Research

SN - 0145-2126

IS - 9

ER -